文献速递神经肿瘤

年轻成人中IDH和H3野生型高级别胶质瘤:一种具有独特表观遗传特征的罕见疾病

High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape.
PubMed 文献 · J Neurooncol · 2025-10-16

年轻成人表观遗传学未分类病例比例高(15.2%),无进展生存期(p=0.003)和总生存期(p=0.001)更长,手术相关不良事件率无差异(p=0.198);在年轻成人中,手术切除与更好的无进展生存期和总生存期相关(p<0.001和p<0.001),DNA甲基化分类显著影响总生存期(p=0.028),而MGMT甲基化状态与无进展生存期和总生存期均无显著关联(p=0.320和p=0.639)。

要点

  • 年轻成人IDH/H3野生型高级别胶质瘤罕见,仅占2.9%。
  • 年轻成人表观遗传学未分类比例高(15.2%)。
  • 年轻成人预后优于年长成人,手术切除改善生存。

核心结论

  • IDH和H3野生型高级别胶质瘤在年轻成人中罕见,预后优于年长成人。
  • 年轻成人DNA甲基化亚型与成人不同,且显著影响生存,而MGMT状态无显著影响。

主要发现

  • 年轻成人(18-39岁)33例,占2.9%。
  • 年轻成人表观遗传学未分类病例5例(15.2%)。
  • 年轻成人无进展生存期(p=0.003)和总生存期(p=0.001)更长。
  • 年轻成人手术相关不良事件率无显著差异(p=0.198)。
  • 年轻成人中手术切除与改善的无进展生存期和总生存期相关(p<0.001和p<0.001)。

关键数值与推荐

  • 表观遗传学未分类占年轻成人的15.2%(5/33)。
  • 手术切除与无进展生存期和总生存期改善相关(p<0.001和p<0.001)。
  • DNA甲基化分类影响总生存期(p=0.028)。
  • MGMT甲基化状态与无进展生存期和总生存期无显著关联(p=0.320和p=0.639)。

临床怎么用

  • 鉴于年轻成人中该病罕见,建议在专业神经肿瘤中心进行专门管理。
  • 年轻成人中手术切除可改善生存,应积极考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: High-grade glioma, IDH- and H3-wildtype in young adults is a rare and poorly known entity. We compared newly diagnosed cases in young adults (18-39 years) to those in adult patients (> 39 years). METHODS: We performed an observational, retrospective, single-centre cohort study at a tertiary neurosurgical oncology centre between January 2006 and December 2023. RESULTS: We included 1.139 adult patients with a newly diagnosed high-grade glioma, IDH- and H3-wildtype. Young adults: (1) represent a small proportion of patients with high-grade glioma (n = 33, 2.9%); (2) have a high rate of unclassified cases based on epigenetics (n = 5, 15.2%); (3) have a longer progression-free survival (p = 0.003) and overall survival (p = 0.001) and; (4) do not have higher surgically-related adverse event rates (p = 0.198). Concerning young adults, surgical resection was associated with improved progression-free and overall survival (p < 0.001 and p < 0.001, respectively). The DNA-methylation class significantly impacts the overall survival (p = 0.028), however, the MGMT methylation status is not significantly associated with either progression-free or overall survival (p = 0.320 and p = 0.639, respectively). CONCLUSION: High-grade glioma, IDH- and H3-wildtype is a rare histo-molecular subtype in young adults with a better prognosis than older adults. In young adults, DNA-methylation subtypes are different from their adult counterpart and had a significant impact on survival unlike MGMT status. Given the rarity in young adults, a dedicated management in specialized neurosurgical oncology centres is preferred. Further molecular and epigenetic analyses are required to understand the differences in prognosis compared to adult patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Roux A, Tauziede-Espariat A, Simboli GA, et al. High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape. J Neurooncol. 2025. PMID: 41099772. doi:10.1007/s11060-025-05246-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。